sever
acut
respiratori
syndrom
sar
newli
found
infecti
diseas
caus
novel
coronaviru
sar
coronaviru
sarscov
di
strain
highli
restrict
host
rang
mutant
vaccinia
viru
replic
pathogen
mice
guinea
pig
rabbit
strain
replic
variou
mammalian
cell
line
recent
establish
system
express
foreign
gene
present
studi
construct
recombin
form
di
contain
gene
encod
four
structur
protein
envelop
e
membran
nucleocapsid
n
spike
sarscov
either
separ
simultan
mammalian
cell
infect
recombin
di
synthes
sarscov
protein
recogn
sar
patient
serum
rabbit
antibodi
rais
synthet
peptid
sarscov
protein
western
blot
analys
intranas
subcutan
inocul
balbc
mice
recombin
di
express
em
emn
protein
elicit
neutral
antibodi
sarscov
protect
immun
therefor
studi
show
replicationdefici
di
strain
feasibl
safe
effect
sar
vaccin
express
sarscov
n
protein
detect
western
blot
use
monoclon
antibodi
robust
signal
detect
kda
correspond
n
nation
institut
infecti
diseas
tokyo
japan
yokota
yasuko
tsunetsuguprotein
sarscov
predict
genom
size
band
near
kda
appear
correspond
protein
known
heavili
glycosyl
concern
protein
smear
band
stack
gel
detect
use
polyclon
antibodi
synthet
peptid
protein
presum
form
larg
ologom
sdsresist
cell
similar
result
observ
analysi
protein
avian
coronaviru
infecti
bronchiti
viru
subcellular
local
n
protein
analyz
immunofluoresc
microscopi
cell
infect
dism
disn
show
n
protein
local
mainli
golgi
complex
consist
studi
model
corona
virus
found
retain
golgi
apparatu
protein
local
golgi
complex
plasma
membran
also
stain
suggest
portion
protein
transport
plasma
membran
thu
result
indic
cell
infect
recombin
di
control
promot
express
signific
level
sarscov
protein
expect
posttransl
process
examin
level
antisarscov
respons
mice
inocul
recombin
di
mice
group
subcutan
intranas
inocul
three
time
whether
immun
sera
possess
neutral
activ
sarscov
crucial
aspect
vaccin
next
estim
neutral
activ
sarscov
antisera
obtain
tabl
neutral
antibodi
sarscov
induc
mice
either
subcutan
intranas
inject
diss
em
emn
among
highest
level
neutral
activ
observ
sera
mice
inject
subcutan
recombin
di
express
e
n
hand
could
detect
neutral
activ
sera
mice
inject
either
subcutan
intranas
recombin
di
express
n
protein
thu
result
indic
recombin
di
induc
potent
sarscovspecif
neutral
antibodi
appear
protein
prerequisit
elicit
suffici
level
igg
antibodi
neutral
activ
highli
attenu
vaccinia
virus
express
viral
insert
gene
high
level
even
nonpermiss
cell
without
show
cpe
rdi
exhibit
replic
abil
produc
infecti
virion
cell
indic
di
strain
may
safeti
advantag
use
recombin
vaccin
vector
effort
direct
vaccin
develop
sarscov
carri
mani
organ
variabl
way
result
show
intranas
subcutan
inocul
balbc
mice
disem
disemn
produc
serum
antibodi
recogn
sarscov
virion
elisa
neutral
sarscov
vitro
moreov
diss
administ
either
rout
elicit
protect
immun
shown
reduc
titer
sarscov
lung
mice
challeng
subcutan
rout
appear
stronger
intranas
rout
respect
level
antisarscov
igg
antibodi
subcutan
inocul
balbc
mice
recombin
di
express
em
emn
protein
elicit
neutral
antibodi
sarscov
therefor
studi
show
replicationdefici
di
strain
feasibl
safe
effect
sar
vaccin
studi
construct
recombin
form
di
contain
gene
encod
four
structur
protein
sarscov
either
separ
simultan
intranas
